Insulin Pumps Beat Daily Injections for Type 1 Diabetes

What Was Studied and Why It Matters

For people living with Type 1 diabetes, managing blood sugar around the clock is a constant challenge. Two common approaches are multiple daily injections (MDI) — where patients inject insulin several times a day — and insulin pump therapy, which delivers insulin automatically through a small device worn on the body.

Researchers at King Fahad Armed Forces Hospital in Jeddah, Saudi Arabia, wanted to know: does switching from daily injections to an insulin pump actually make a measurable difference? They followed 24 Type 1 diabetes patients (average age 23) for six months after they transitioned to pump therapy, comparing their results to when they were on injections.

What the Researchers Found

The results were clear and encouraging. After just six months on an insulin pump, patients saw significant improvements across nearly every important blood sugar measure:

• Lower HbA1c levels — the key three-month average blood sugar reading dropped meaningfully, indicating better overall control
• More time in target range — patients spent more of each day with blood sugar in the healthy zone
• Less time dangerously low — episodes of low blood sugar (hypoglycemia) became less frequent and less severe
• Fewer hospital admissions for diabetic ketoacidosis (DKA) — a serious and potentially life-threatening complication that requires emergency care
• Greater meal flexibility — patients reported more freedom around food timing and choices

Most patients (91.7%) used the MiniMed 780G system, an advanced hybrid closed-loop pump that automatically adjusts insulin delivery based on continuous glucose readings. All participants also completed carbohydrate-counting training before starting pump therapy.

What This Means for Real Patients

If you or someone you care for is managing Type 1 diabetes with multiple daily injections and struggling to keep blood sugar stable, this study adds to a growing body of evidence that insulin pump therapy can make a real difference — not just in numbers, but in daily life quality.

Fewer low blood sugar episodes means less anxiety and disruption. Fewer DKA hospitalizations means less time in emergency rooms and lower medical costs. More meal flexibility means less stress around food — something every person with diabetes understands deeply.

Managing pump therapy also requires reliable supplies and monitoring tools. Having consistent access to CGM sensors, pump consumables, and other diabetes essentials is critical to getting these results. MDS Diabetes provides a wide range of diabetes supplies that support patients using both pump therapy and CGM systems, helping ensure you have what you need without interruption.

Important Considerations

This was a relatively small study (24 patients) at a single hospital, so larger research is still needed. Insulin pump therapy also requires training, commitment, and ongoing support. It isn't the right fit for everyone, and cost or access barriers remain a real challenge for many patients globally.

Bottom Line

Switching from multiple daily injections to an insulin pump was associated with significantly better blood sugar control, fewer dangerous low blood sugar episodes, and fewer hospitalizations for diabetic ketoacidosis in Type 1 diabetes patients — all within six months. If you are currently on MDI therapy and experiencing challenges with control, it may be worth asking your diabetes care team whether pump therapy is right for you.